Skip to main content
SCI logo

SCI — Investor Relations & Filings

Ticker · 4119 ISIN · TW0004119003 TW Manufacturing
Open in API
Filings indexed 1,697 across all filing types
Latest filing 2023-06-08 Director's Dealing
Country TW Taiwan
Listing TW 4119

About SCI

www.sci-pharmtech.com.tw

SCI Pharmtech, Inc. specializes in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. Established in 1987 and originally founded by the Swiss Siegfried Group, the company provides high-quality chemical solutions and custom manufacturing services to leading global pharmaceutical corporations across Europe, North America, and Japan. Its core operations encompass advanced chemical synthesis, process optimization, and large-scale production within GMP-compliant facilities. With a robust R&D infrastructure including specialized laboratories and pilot plants, the company delivers technical excellence in complex chemical processing. SCI Pharmtech maintains a strong focus on quality assurance and international regulatory compliance, positioning itself as a reliable partner for the global healthcare and life sciences sectors.

Recent filings

Filing Released Lang Actions
112年05月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, managers, and their related parties, showing changes in share ownership. It lists share counts at different times and categories, indicating insider holdings and transactions. There is no indication of financial statements, earnings data, or report publication announcements. The content matches the description of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document length is sufficient and contains substantive data on insider shareholdings and changes, consistent with the DIRS category.
2023-06-08 Chinese
112年05月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by company insiders, including directors, managers, and related parties, showing their current holdings, pledged shares, and related percentages. It is focused on insider share ownership disclosures rather than financial results, management changes, or meeting materials. There is no indication of a report publication, earnings release, or regulatory certification. The content aligns with a Director's Dealing report, which typically discloses personal share transactions or holdings by company directors and executives. The document length is under 5,000 characters and contains detailed insider shareholding data, consistent with a Director's Dealing filing rather than a general regulatory announcement or other categories.
2023-06-08 Chinese
112年5月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (旭富) providing information about fund lending balances and endorsement guarantees for the current and previous months, including cumulative amounts and limits. The content is concise, numerical, and regulatory in nature, without detailed financial statements or management discussion. It does not present a full report but rather a regulatory compliance disclosure. Given the short length (601 characters) and the nature of the data, this fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-06-08 Chinese
112年5月營業收入
Fund Information / Factsheet Classification · 85% confidence The document is a summary report of monthly and cumulative net operating revenue for a company named 旭富, with figures for May 2023 (民國112年05月) and comparisons to the previous year. It includes explanations for revenue changes and accounting standards references (IFRS). The document is very short (788 characters) and contains financial data but is more of a brief revenue summary rather than a full financial report. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It is also not an announcement or notice about a report publication. Given the nature of the content—a brief financial summary focusing on key revenue figures and explanations—it best fits the category of Fund Information / Factsheet (FS), which is defined as a brief summary of key company facts and financials.
2023-06-08 Chinese
112年05月法人說明會簡報 — 411920230517E001.pdf
Regulatory Filings
2023-05-17 Chinese
112年05月法人說明會簡報 — 411920230517M001.pdf
Regulatory Filings
2023-05-17 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.